Type 2 Diabetes - Drug Pipeline Analysis and Market Forecasts to 2016

Table of Contents

1 Type 2 Diabetes Market: Executive Summary
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Type 2 Diabetes Market: Market Characterization
3.1 Overview
3.2 Type 2 Diabetes Market Size
3.3 Type 2 Diabetes Market Forecast and CAGR
3.4 Drivers and Barriers for Type 2 Diabetes Market
3.4.1 Drivers for Type 2 Diabetes Market
3.4.2 Barriers for Type 2 Diabetes Market
3.5 Opportunity and Unmet Need
3.6 Key Takeaway
4 Type 2 Diabetes Market: Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles of the Major Marketed Products
4.3.1 Overview
4.3.2 Efficacy
4.3.3 Safety Profile
4.3.4 Pricing
4.3.5 Clinical Study Details
4.4 Key Takeaway
5 Type 2 Diabetes Market: Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.2.1 Technology Trends Analytical Framework
5.3 Type 2 Diabetes Therapeutics – Promising Drugs under Clinical Development
5.4 Molecule Profiles of Promising Drugs under Clinical Development
5.4.1. Overview
5.4.2 Efficacy
5.4.3 Safety
5.4.4 Clinical Study Details
5.5 Type 2 Diabetes Therapeutics Market – Clinical Pipeline by Mechanism of Action
5.6 Type 2 Diabetes Pipeline – Pipeline by Clinical Phases of Development
5.6.1 Type 2 Diabetes Therapeutics – Phase III Clinical Pipeline
5.6.2 Type 2 Diabetes Therapeutics – Phase II Clinical Pipeline
5.6.3 Type 2 Diabetes Therapeutics – Phase I Clinical Pipeline
5.6.4 Type 2 Diabetes Therapeutics – Preclinical Pipeline
5.6.5 Type 2 Diabetes Therapeutics – Discovery Pipeline
5.7 Discontinued / Suspended Drugs for Type 2 Diabetes
5.8 Key Takeaway
6 Type 2 Diabetes Market: Implications for Future Market Competition
7 Type 2 Diabetes Market: Future Players in Type 2 Diabetes Market
8 Type 2 Diabetes Market: Appendix
8.1 Definitions
8.2 Acronyms
8.3 Research Methodology
8.3.1 Coverage
8.3.2 Secondary Research
8.3.3 Forecasting
8.3.3.1 Epidemiology-based Forecasting
8.3.4 Primary Research
8.3.5 Expert Panel validation
8.4 Contact Us
8.5 Disclaimer
8.6 Sources
List of Tables

Table 1: Global Type 2 Diabetes Treatment by Stage of the Disease, 2009
Table 2: Global Type 2 Diabetes Therapeutics Market, Revenue Forecasts ($ m), 2001-2009
Table 3: Global Type 2 Diabetes Therapeutics Market, Revenue Forecasts ($ m), 2009-2016
Table 4: Major marketed products comparison in Type 2 Diabetes, 2009
Table 5: Type 2 Diabetes Therapeutics – Most Promising Drugs Under Clinical Development, 2009
Table 6: Type 2 Diabetes Therapeutics – Phase III Clinical Pipeline, 2009
Table 7: Type 2 Diabetes Therapeutics – Phase II Clinical Pipeline, 2009
Table 8: Type 2 Diabetes Therapeutics – Phase I Clinical Pipeline, 2009
Table 9: Type 2 Diabetes Therapeutics – Preclinical Pipeline, 2009
Table 10: Type 2 Diabetes Therapeutics – Drug Discovery Pipeline, 2009
Table 11: Type 2 Diabetes Therapeutics – List of Discontinued Drugs, 2009 List of Figures

Figure 1: Global Type 2 Diabetes Therapeutics Market Forecast, 2000-2015
Figure 2: Type 2 Diabetes Therapeutics Market – Opportunity and Unmet Need, 2009
Figure 3: Type 2 Diabetes Therapeutics Market – Strategic Competitor Assessment, 2009
Figure 4: Technology Trends Analytic Framework of the Type 2 Diabetes Pipeline, 2009
Figure 5: Technology Trends Analytic Framework of the Type 2 Diabetes Pipeline – Description, 2009
Figure 6: Type 2 Diabetes Therapeutics Market – Clinical Pipeline by Mechanism of Action, 2009
Figure 7: Type 2 Diabetes Pipeline by Phase of Clinical Development, 2009
Figure 8: Type 2 Diabetes Therapeutics Market – Strategic Competitor Assessment, 2009
Figure 9: Type 2 Diabetes Therapeutics Market – Clinical Pipeline by Company, 2009
Figure 10: Methodology
Figure 11: Market Forecasting Model